Meeting
Abstract Number: 0298
SHM Converge 2025
Background: Transitioning from inpatient to outpatient care is high-risk, often associated with harm from incomplete or ineffective communication of clinical information [1]. In one report, 41% of patients had at least one pending study at the time of discharge, 43% of which were abnormal and 9.4% potentially actionable [2]. The discharge summary is a ubiquitous [...]
Abstract Number: 0429
SHM Converge 2025
Background: Within 3 weeks of hospital discharge, about 19% of patients experience an adverse event, with 66% of these being an adverse drug event. During a patient’s transition from hospital to home, pharmacists have identified and resolved medication discrepancies. Inappropriate continuation or discontinuation of medications post-hospital discharge often stems from medication list complexity, inconsistent or [...]
Abstract Number: 0570
SHM Converge 2025
Case Presentation: A 47-year-old body builder with a history of anabolic steroid use, five recent subcutaneous infections thought to be due to non-sterile street drugs, and recent development of CKD 2 was admitted for left lateral thigh cellulitis and mild AKI. Following IV antibiotic initiation, patient reported worsening leg pain. MRI of the leg identified [...]